Literature DB >> 15531752

Systemic inflammatory response and progression to severe sepsis in critically ill infected patients.

Corinne Alberti1, Christian Brun-Buisson, Sylvie Chevret, Massimo Antonelli, Sergey V Goodman, Claudio Martin, Rui Moreno, Ana R Ochagavia, Mark Palazzo, Karl Werdan, Jean Roger Le Gall.   

Abstract

RATIONALE: The systemic inflammatory response syndrome has low specificity to identify infected patients at risk of worsening to severe sepsis or shock.
OBJECTIVE: To examine the incidence of and risk factors for worsening sepsis in infected patients.
METHODS: A 1-year inception cohort study in 28 intensive care units of patients (n = 1,531) having a first episode of infection on admission or during the stay.
MEASUREMENTS AND MAIN RESULTS: The cumulative incidence of progression to severe sepsis or shock was 20% and 24% at Days 10 and 30, respectively. Variables independently associated (hazard ratio [HR]) with worsening sepsis included: temperature higher than 38.2 degrees C (1.6), heart rate greater than 120/minute (1.3), systolic blood pressure higher than 110 mm Hg (1.5), platelets higher than 150 x 109/L (1.5), serum sodium higher than 145 mmol/L (1.5), bilirubin higher than 30 mumol/L (1.3), mechanical ventilation (1.5), and five variables characterizing infection (pneumonia [HR 1.5], peritonitis [1.5], primary bacteremia [1.8], and infection with gram-positive cocci [1.3] or aerobic gram-negative bacilli [1.4]). The 12 weighted variables were included in a score (Risk of Infection to Severe Sepsis and Shock Score, range 0-49), summarized in four classes of "low" (score 0-8) and "moderate" (8.5-16) risk (9% and 17% probability of worsening, respectively), and of "high" (16.5-24) and "very high" (score > 24) risk (31% and 55% probability, respectively).
CONCLUSIONS: One of four patients presenting with infection/sepsis worsen to severe sepsis or shock. A score estimating this risk, using objectively defined criteria for systemic inflammatory response syndrome, could be used by physicians to stratify patients for clinical management and to test new interventions.

Entities:  

Mesh:

Year:  2004        PMID: 15531752     DOI: 10.1164/rccm.200403-324OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  55 in total

1.  Functional status does not predict complicated clinical course in older adults in the emergency department with infection.

Authors:  Jeffrey M Caterino; Robert A Murden; Kurt B Stevenson
Journal:  J Am Geriatr Soc       Date:  2012-01-27       Impact factor: 5.562

2.  Severe bacteremia results in a loss of hepatic bacterial clearance.

Authors:  Alix Ashare; Martha M Monick; Linda S Powers; Timur Yarovinsky; Gary W Hunninghake
Journal:  Am J Respir Crit Care Med       Date:  2006-01-06       Impact factor: 21.405

3.  Incidence of sepsis in hospitalized patients.

Authors:  Rui Moreno; Susana Afonso; Teresa Fevereiro
Journal:  Curr Infect Dis Rep       Date:  2006-09       Impact factor: 3.725

4.  The Severity of ICU-Acquired Pneumonia.

Authors:  Hugues Marechal; Nathalie Layios; Pierre Damas
Journal:  Curr Infect Dis Rep       Date:  2013-10       Impact factor: 3.725

5.  The role of infection and comorbidity: Factors that influence disparities in sepsis.

Authors:  Annette M Esper; Marc Moss; Charmaine A Lewis; Rachel Nisbet; David M Mannino; Greg S Martin
Journal:  Crit Care Med       Date:  2006-10       Impact factor: 7.598

6.  Association of prior antiplatelet agents with mortality in sepsis patients: a nationwide population-based cohort study.

Authors:  Min-Juei Tsai; Shuo-Ming Ou; Chia-Jen Shih; Pei-Wen Chao; Lan-Fu Wang; Yu-Ning Shih; Szu-Yuan Li; Shu-Chen Kuo; Yen-Tao Hsu; Yung-Tai Chen
Journal:  Intensive Care Med       Date:  2015-04-01       Impact factor: 17.440

Review 7.  Will polymerase chain reaction (PCR)-based diagnostics improve outcome in septic patients? A clinical view.

Authors:  Mathias W Pletz; Nele Wellinghausen; Tobias Welte
Journal:  Intensive Care Med       Date:  2011-05-15       Impact factor: 17.440

8.  T helper type 2-polarized invariant natural killer T cells reduce disease severity in acute intra-abdominal sepsis.

Authors:  R V Anantha; D M Mazzuca; S X Xu; S A Porcelli; D D Fraser; C M Martin; I Welch; T Mele; S M M Haeryfar; J K McCormick
Journal:  Clin Exp Immunol       Date:  2014-11       Impact factor: 4.330

9.  Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study.

Authors:  Jesús Blanco; Arturo Muriel-Bombín; Víctor Sagredo; Francisco Taboada; Francisco Gandía; Luís Tamayo; Javier Collado; Angel García-Labattut; Demetrio Carriedo; Manuel Valledor; Martín De Frutos; María-Jesús López; Ana Caballero; José Guerra; Braulio Alvarez; Agustín Mayo; Jesús Villar
Journal:  Crit Care       Date:  2008-12-17       Impact factor: 9.097

10.  Early drotrecogin alpha (activated) administration in severe sepsis is associated with lower mortality: a retrospective analysis of the Canadian ENHANCE cohort.

Authors:  Richard V Hodder; Richard Hall; James A Russell; Harold N Fisher; Bobbie Lee
Journal:  Crit Care       Date:  2009-05-20       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.